{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:40:18Z","timestamp":1775706018510,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:italic>Background<\/jats:italic>. Fabry disease is an X\u2010linked genetic disorder resulting in the accumulation of glycosphingolipids in various organs, leading to exercise intolerance and early mortality. Enzyme replacement therapy (ERT) has recently been approved for use in Fabry patients. <jats:italic>Goals of study<\/jats:italic>. To assess baseline cardiopulmonary exercise characteristics in both invasive and noninvasive tests and to study the impact of ERT on exercise. <jats:italic>Methods<\/jats:italic>. A total of 15 patients with Fabry disease underwent baseline cardiopulmonary exercise tests. Six patients were randomized 2:1 to receive either ERT or placebo. We performed serial cardiopulmonary exercise tests at baseline and every 3 months over a period of at least 18 months. The baseline test was compared to the last two exercise tests for each patient. <jats:italic>Results<\/jats:italic>. Mean age was 32 years. Mean VO<jats:sub>2<\/jats:sub> max was 1.680 \u00b1 0.67 L\/min and increased by 0.459 \u00b1 0.64 L\/min in the patients receiving ERT. Mean VO<jats:sub>2<\/jats:sub> max was 1.462 \u00b1 0.25 L\/min and decreased by 0.116 \u00b1 0.44 L\/min in patients on placebo. Mean oxygen pulse (VO<jats:sub>2<\/jats:sub>\/HR) increased by 1.71 with enzyme, but increased only 0.025 in patients taking placebo. Estimated stroke volume (SV) increased by 10 ml in patients on ERT. <jats:italic>Conclusions<\/jats:italic>. In this small cohort, exercise tolerance increased in patients receiving enzyme replacement therapy. Cardiopulmonary exercise testing is a useful test in measuring the response to therapy in Fabry disease patients.<\/jats:p>","DOI":"10.1007\/s10545-006-0361-5","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T23:43:53Z","timestamp":1151711033000},"page":"572-579","source":"Crossref","is-referenced-by-count":48,"title":["Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease"],"prefix":"10.1002","volume":"29","author":[{"given":"Gregory","family":"Bierer","sequence":"first","affiliation":[{"name":"Division of Pulmonary\/Critical Care Medicine Cedars\u2010Sinai Medical Center and UCLA School of Medicine Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Balfe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Cedars\u2010Sinai Medical Center and UCLA School of Medicine Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics Cedars\u2010Sinai Medical Center and UCLA School of Medicine Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zab","family":"Mosenifar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Cedars\u2010Sinai Medical Center and UCLA School of Medicine Los Angeles California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.5.1202"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2005.04.009"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90194-5"},{"key":"e_1_2_1_6_1","first-page":"2743","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Beaudet AL","year":"1995"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01424.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000087675"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.3.9116979"},{"key":"e_1_2_1_10_1","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxIDe diffusing capacity","volume":"123","author":"Crapo RO","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.8.720"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.105105"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000131534.25034.43"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000061952.27445.A0"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90224-7"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.3.8845993"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.1023"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-0736(82)80010-1"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1997.82.3.908"},{"key":"e_1_2_1_21_1","volume-title":"Principles of Exercise Testing and Interpretation","author":"Wasserman K","year":"1999"},{"issue":"2","key":"e_1_2_1_22_1","first-page":"386","article-title":"Transvenous permanent pacemaker implantation for Fabry's disease. 3 cases report","volume":"37","author":"Yoshida K","year":"1989","journal-title":"Nippon Kyobu Geka Gakkai Zasshi\u2013\u2010J Jpn Assoc Thorac Surg"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-006-0361-5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-006-0361-5","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-006-0361-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:53:56Z","timestamp":1694782436000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-006-0361-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1007\/s10545-006-0361-5"],"URL":"https:\/\/doi.org\/10.1007\/s10545-006-0361-5","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}